UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 8-K



CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) October 16, 2009



athenahealth, Inc.
(Exact name of registrant as specified in its charter)

Delaware

001-33689

04-3387530

(State or other jurisdiction

of incorporation)

(Commission
File Number)

(IRS Employer
Identification No.)

 

311 Arsenal Street, Watertown, MA

 

02472

(Address of principal executive offices)

(Zip Code)


Registrant’s telephone number, including area code:   617-402-1000


 

(Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 8.01 Other Events.

On October 16, 2009, athenahealth, Inc. completed its previously announced acquisition of Anodyne Health Partners, Inc. A copy of the press release announcing the closing is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information in this report, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.   Description
99.1 Press release issued by athenahealth, Inc. on October 19, 2009, furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

athenahealth, Inc.

(Registrant)

 

October 19, 2009

/s/  DANIEL H. ORENSTEIN

 

Daniel H. Orenstein

VP, General Counsel, and Secretary


EXHIBIT INDEX

Exhibit No.

 

Description

99.1

Press release issued by athenahealth, Inc. on October 19, 2009, furnished herewith.